Back to results
US 8,278,321 B2Granted
Small molecule inhibition of intracellular transport
AssigneeWashington University
InventorDavid B. Haslam
Life of this patent
Estimating the term…
Abstract
The present disclosure characterizes the activity of Golgicide A (GCA), as a potent, specific and reversible small molecule inhibitor of Golgi BFA resistance factor 1 (GBF1) function. A mutant GBF1 gene that is resistant to GCA is also described. Methods of using GCA and the GCA-resistant GBF1 gene are described including methods for modulating GBF1 activity for research and therapeutic purposes. Also described are compositions incorporating a GCA-resistant GBF1.
Claims9
A method of inhibiting Golgi BFA resistance factor (GBF1) in a eukaryotic cell, the method comprising contacting the cell with Golgicide A.
Dependencies are inferred from the claim text.